search

Active clinical trials for "Colorectal Neoplasms"

Results 2151-2160 of 4253

Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

Colorectal CancerMetastatic Cancer

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Phase II trial to study the effectiveness of vaccine therapy in treating patients who have colorectal cancer that has spread to the liver.

Completed48 enrollment criteria

Acupuncture to Reduce Symptoms of Advanced Colorectal Cancer

Colorectal Neoplasms

This study investigates the effect of acupuncture in reducing symptom distress in adults with advanced colon cancer.

Completed11 enrollment criteria

Comparison of Barium Enema, Computed Tomographic Colonography, and Colonoscopy in Detecting Colon...

Colorectal Cancer

RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for cancer. New diagnostic procedures such as computed tomographic colonography may provide a less invasive method of identifying patients who have colon cancer. PURPOSE: Diagnostic and screening trial to compare the effectiveness of barium enema, computed tomographic colonography, and colonoscopy in detecting of colon cancer.

Terminated55 enrollment criteria

Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver...

Colorectal CancerMetastatic Cancer

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving drugs in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of surgery followed by floxuridine plus systemic fluorouracil and leucovorin in treating patients with liver metastases from colorectal cancer.

Completed41 enrollment criteria

Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Colorectal Cancer

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of irinotecan in treating patients who have metastatic or recurrent colorectal cancer.

Completed3 enrollment criteria

Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer

Colorectal Cancer

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I/II trial to study the effectiveness of amifostine plus irinotecan in treating patients with metastatic colorectal cancer.

Completed19 enrollment criteria

Flt3L in Treating Patients With Metastatic Colorectal Cancer

Colorectal CancerMetastatic Cancer

RATIONALE: Flt3L may stimulate a person's immune system and help kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of flt3L given to patients before undergoing surgery to remove metastases from colorectal cancer.

Completed3 enrollment criteria

Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Colorectal Cancer

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of trimetrexate glucuronate, fluorouracil, and leucovorin in treating patients with recurrent or metastatic colorectal cancer.

Completed3 enrollment criteria

Conventional Surgery Compared With Laparoscopic-Assisted Surgery in Treating Patients With Colorectal...

Colorectal Cancer

RATIONALE: Laparoscopic-assisted surgery is a less invasive type of surgery for colorectal cancer and may have fewer side effects and improve recovery. It is not yet known if undergoing conventional surgery is more effective than laparoscopic-assisted surgery for colorectal cancer. PURPOSE: This randomized phase III trial is studying conventional surgery to see how well it works compared to laparoscopic-assisted surgery in treating patients with colorectal cancer.

Completed38 enrollment criteria

Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Colorectal Cancer

Colorectal Cancer

RATIONALE: Monoclonal antibodies can locate tumor cells and deliver tumor-killing substances, such as radioactive iodine, to them without harming normal cells. PURPOSE: Phase I trial to study the effectiveness of radiolabeled monoclonal antibody in treating patients with advanced colorectal cancer.

Completed3 enrollment criteria
1...215216217...426

Need Help? Contact our team!


We'll reach out to this number within 24 hrs